The concept of adoptive cell therapy is a cornerstone of modern immunotherapy, where a patient's own immune cells are used to fight their cancer. The most successful form of this approach is chimeric antigen receptor (CAR) T-cell therapy, a prime example of personalized oncology therapies. The synergy between these two concepts is fundamental: adoptive cell therapy provides...

According to the latest report published by Data Bridge Market Research, the Topoisomerase Inhibitors Market  CAGR Value The global topoisomerase inhibitors market size was valued at USD 5.49 billion in 2025 and is expected to reach USD 8.17 billion by 2033, at a CAGR of 5.10% during the forecast period Salient attributes used while forming an influential Topoisomerase Inhibitors...

Market Overview Biomarker-driven patient selection is optimizing Keytruda outcomes through precision oncology approaches. Biomarkers optimize treatment through identifying patients most likely to benefit from therapy. Current Market Landscape PD-L1 expression assessment. Tumor mutational burden testing. Microsatellite instability evaluation. DNA mismatch repair deficiency. Genomic profiling....

The field of oncology is being transformed by the convergence of virology and genetics, leading to the development of powerful gene-based oncology therapies. Tumor-targeted virotherapy is a prime example of this convergence, using viruses as vectors to deliver therapeutic genes directly to cancer cells. This approach not only destroys the tumor but can also be used to modulate...

According to the latest report published by Data Bridge Market Research, the Hodgkin Lymphoma Drug Market  CAGR Value The global Hodgkin Lymphoma Drug market size was valued at USD 3.50 billion in 2025 and is expected to reach USD 10.52 billion by 2033, at a CAGR of 14.75% during the forecast period This Hodgkin Lymphoma Drug Market research report has been formed with a...